You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Policy & Regulation
Ribo and Madrigal sign global siRNA licensing deal
Login
Username:

Password:


Related Headlines

Arctic Therapeutics enrols first patients in Phase IIa trial of AT-004 for acne vulgaris

IP Group plc portfolio company Microbiotica reports positive Phase 1b data for MB310 in ulcerative colitis

Ribo and Madrigal sign global siRNA licensing deal

Galderma launches Restylane Defyne and Refyne in Japan

Aptamer Optimer technology integrated into Twist Bioscience TrueAmp Library Preparation Kit

AsymBio builds integrated platforms across biopharmaceutical development lifecycle

Evogene expands Google Cloud collaboration to integrate AI agents into ChemPass AI

Cumulus Neuroscience enters Japanese market with Shionogi collaboration

FDA accepts Takeda's oveporexton NDA with priority review for narcolepsy type 1

Eli Lilly signs definitive agreement to acquire Orna Therapeutics

CiteAb launches new scientific image search tool and improved reagent search engine

Innocan Pharma reports findings from clinical study of LPT-CBD in dogs

Lunai Bioworks starts new oncology collaboration with clinical-stage partner

BioArctic and Eisai secure Priority Review in China for subcutaneous Leqembi

Sanofi's rilzabrutinib receives FDA breakthrough and Japan orphan designations for rare anaemia

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026